ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: ICC Had Only Planning, Not Core Support Grant; Number Of Ro1s In ’79 Understated

June 23, 1978

Cancer Survivors Day Planned or June 5

April 22, 1988

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

NCAB Subcommittee Worries About Board’s Makeup

January 19, 1979

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012